Severe Heart Failure and Homebased Rehabilitation - An Intersectoral Randomized Controlled Trial

NCT ID: NCT01669395

Last Updated: 2012-08-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-09-30

Study Completion Date

2016-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to investigate the effect of an early, coordinated rehabilitation intervention for patients with severe heart failure in NYHA class III and IV with a ejection fraction of \<40% of normal cardiac function measured on frequency of readmissions, physical ability and participation in activities of daily living and quality of life.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Approximately 400,000 Danes live today with heart disease. Disease severity is crucial for patients quality of life. Patients with severe heart disease often struggle with everyday life, characterized by reduced physical capacity, tendency to depression and anxiety to perform everyday activities that may provoke symptoms.

A large proportion of patients who are offered cardiac rehabilitation deselect that offer. Of the patients who do participate, more than 50% stop the rehabilitation ahead of time. A large group of patients with severe heart failure and classified in NYHA Class III and IV, deselect the offer because of lack of energy to participate in cardiac rehabilitation or is when specified by a medical assessment discharged from the hospital without the offer of training or any other form of rehabilitation.

The offer of rehabilitation for patients with severe heart failure is lacking as it is today. This study assesses the effectiveness of an early home based rehabilitation program that complements the general psycho-social support, symptom-oriented and preventive medical treatment that these patients always have the option to get.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Heart Failure Heart Failure NYHA Class II Heart Failure NYHA Class III Heart Failure NYHA Class IV

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Severe heart failure Homebased rehabilitation Physical exercise Activities of daily living Intersectoral Cooperation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Early homebased rehabilitation

After discharge from the hospital patients are offered a homebased rehabilitation program lasting 6 weeks.

Group Type EXPERIMENTAL

Early homebased rehabilitation after hospital admission

Intervention Type OTHER

Training begins 3-5 days after discharge from hospital, performed by an occupational therapist and a physiotherapist from Gentofte Hospital in the first two weeks. From week three to six the training will be carried out by an occupational therapist and a physiotherapist from the local municipality (Gentofte municipality and Lyngby Taarbæk municipality). Training will take place at home twice a week for 6 weeks, each session lasting 45 minutes. The intervention is individualized and focuses on functional physical and compensatory training to help the patient to manage everyday life at home. A training program will be provided and the patient will be instructed to do the exercises every day

control group: Ususal care

After discharge from the hospital the patients are offered the usual symptom-oriented and preventive medical care and psychosocial support

Group Type EXPERIMENTAL

Usual care

Intervention Type OTHER

After discharge from the hospital the patients are offered the usual symptom-oriented and preventive medical care and psychosocial support

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Early homebased rehabilitation after hospital admission

Training begins 3-5 days after discharge from hospital, performed by an occupational therapist and a physiotherapist from Gentofte Hospital in the first two weeks. From week three to six the training will be carried out by an occupational therapist and a physiotherapist from the local municipality (Gentofte municipality and Lyngby Taarbæk municipality). Training will take place at home twice a week for 6 weeks, each session lasting 45 minutes. The intervention is individualized and focuses on functional physical and compensatory training to help the patient to manage everyday life at home. A training program will be provided and the patient will be instructed to do the exercises every day

Intervention Type OTHER

Usual care

After discharge from the hospital the patients are offered the usual symptom-oriented and preventive medical care and psychosocial support

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

severe heart failure homebased rehabilitation physical exercise activities of daily living

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients admitted to the Gentofte Hospital due to heart failure.
* Patients with a functional equivalent to NYHA grade III or IV
* Patients with ejection fraction \<40%
* Patients who score between10-15 in the total score for question 3 dealing with physical functioning in SF-36 questionnaire on health status
* Patients who lives in Gentofte Municipality or Lyngby Tårbæk Municipality.
* Patients who can speak and understand Danish

Exclusion Criteria

* Patients with cognitive and psychological problems that prevents cooperation (aphasia, dementia, severe depression).
* Patients with terminal illness with expected death within a year.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Gentofte, Copenhagen

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Laura Staun Valentiner

Research and Development Physiotherapist

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Occupational Therapy and Physiotherapy, Copenhagen University Hospital Gentofte,

Copenhagen, Gentofte, Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Laura Staun Valentiner, Master in health scien

Role: CONTACT

Phone: + 45 39 77 39 51

Email: [email protected]

Carsten Juhl, Ph.D.stud

Role: CONTACT

Phone: + 45 39 77 39 51

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Laura Staun Valentiner, masters in health sciences

Role: primary

Carsten Juhl, Ph.D stud.

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

H-2-2012-021

Identifier Type: -

Identifier Source: org_study_id